Search

everythinglearnresearchcommunity

for

Search:↓

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

A woman developed a severe skin reaction called toxic epidermal necrolysis after taking the antibiotic cephalexin.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Lokivetmab reduced itching in a dog with skin lymphoma.

Cyclosporin is effective in treating dog skin diseases and has fewer side effects compared to other treatments.

Baicalin may help treat severe drug-induced skin reactions.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Intravenous cyclophosphamide effectively treated steroid-resistant lupus cystitis and peritonitis.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

A CCS patient with severe complications was successfully treated using combined therapies.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.